Skip to Content

PRIMECAP Odyssey Aggressive Growth POAGX

Medalist Rating as of | See PRIMECAP Investment Hub
  • NAV / 1-Day Return 44.19  /  −0.61 %
  • Total Assets 7.0 Bil
  • Adj. Expense Ratio
    0.660%
  • Expense Ratio 0.660%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Mid-Cap Growth
  • Investment Style Mid Growth
  • Min. Initial Investment 2,000
  • Status Open
  • TTM Yield 0.02%
  • Turnover 5%

USD | NAV as of May 10, 2024 | 1-Day Return as of May 10, 2024, 10:16 PM GMT+0

Morningstar’s Analysis POAGX

Will POAGX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

Rekindling past success.

Strategist Robby Greengold

Robby Greengold

Strategist

Summary

With its outstanding investment team and high-conviction multimanager approach, Primecap Odyssey Aggressive Growth is exemplary within the mid-growth Morningstar Category.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings POAGX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 29.8
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Eli Lilly and Co

6.35 457.7 Mil
Healthcare

Dreyfus Treasury Secs Cash Mgmt Inst

5.31 383.1 Mil
Corporate

Micron Technology Inc

4.78 344.6 Mil
Technology

Rhythm Pharmaceuticals Inc

3.10 223.8 Mil
Healthcare

Biogen Inc

2.64 190.4 Mil
Healthcare

Sony Group Corp ADR

2.46 177.4 Mil
Technology

Biomarin Pharmaceutical Inc

2.36 170.0 Mil
Healthcare

Flex Ltd

2.30 165.6 Mil
Technology

AECOM

2.17 156.8 Mil
Industrials

Jacobs Solutions Inc

1.80 129.9 Mil
Industrials